Nonalcoholic Fatty Liver Disease (NAFLD): Mechanisms and Novel Therapeutics

Thanks to our generous Symposium sponsors, including Ed and Lynn Taff, the George Blackburn Foundation, Steve Sim and Marilyn Einstein, and our industry sponsors.  21st Annual Harvard Nutrition and Obesity Symposium received support from the following companies in the form of educational grants:  Intercept Pharmaceuticals and Theratechnologies, Inc.  Other financial relationships may exist between these companies and Massachusetts General Hospital.